Table 6.
Number and stage of lung cancer patients, with diagnosis by source of referral.
| 2015 Number of cases (%) | 2016 Number of cases (%) | n change | p-value | |
|---|---|---|---|---|
| Number of new lung cancer cases | ||||
| Non-small cell lung cancer | ||||
| Pre-campaign | 324 | 326 | 2 | |
| Campaign | 348 | 372 | 24 | 0.34 |
| Post-campaign | 342 | 318 | −24 | |
| Small-cell lung cancer | ||||
| Pre-campaign | 51 | 47 | −4 | |
| Campaign | 53 | 40 | −13 | 0.38 |
| Post-campaign | 42 | 39 | −3 | |
| Total | ||||
| Pre-campaign | 375 | 373 | −2 | |
| Campaign | 401 | 412 | 11 | 0.70 |
| Post-campaign | 384 | 357 | −27 | |
| 2015 Number of cases (%) | 2016 Number of cases (%) | % Change | p-value | |
|---|---|---|---|---|
| Stage of new lung cancer cases number and proportion of cases with known stagea | ||||
| Early (stage I and II) | ||||
| Pre-campaign | 95 (25.5%) | 85 (23.4%) | −2.1% | |
| Campaign | 98 (24.8%) | 114 (28.3%) | 3.5% | 0.27 |
| Post-campaign | 114 (30.2%) | 94 (27.0%) | −3.2% | |
| Late (stage III and IV) | ||||
| Pre-campaign | 277 (74.5%) | 278 (76.6%) | 2.1% | |
| Campaign | 297 (75.1%) | 289 (71.7%) | −3.5% | 0.27 |
| Post-campaign | 263 (69.8%) | 254 (73.0%) | 3.2% | |
| Stage unknown | ||||
| Pre-campaign | 3 | 10 | ||
| Campaignb | 6 | 9 | ||
| Post-campaign | 7 | 9 | ||
| Number and proportion of new lung cancer cases diagnosed by source of referral | ||||
| Following A&E attendance or emergency admission | ||||
| Pre-campaign | 102 (27.2%) | 111 (29.8%) | 2.6% | |
| Campaign | 89 (22.2%) | 117 (28.5%) | 6.3% | 0.04 |
| Post-campaign | 103 (26.8%) | 108 (30.3%) | 3.4% | |
| Referral from GP | ||||
| Pre-campaign | 176 (46.9%) | 184 (49.3%) | 2.4% | |
| Campaign | 180 (44.9%) | 171 (41.6%) | −3.3% | 0.35 |
| Post-campaign | 154 (40.1%) | 146 (40.9%) | 0.8% | |
| Referral from a consultant (other than in an A&E department) | ||||
| Pre-campaign | 73 (19.5%) | 57 (15.3%) | −4.2% | |
| Campaign | 112 (27.9%) | 85 (20.7%) | −7.2% | 0.02 |
| Post−campaign | 103 (26.8%) | 77 (21.6%) | −5.3% | |
| Referral from a consultant (from inpatients) | ||||
| Pre-campaign | 13 (3.5%) | 9 (2.4%) | −1.1% | |
| Campaign | 16 (4.0%) | 24 (5.8%) | 1.8% | 0.22 |
| Post-campaign | 11 (2.9%) | 16 (4.5%) | 1.6% | |
| Other source | ||||
| Pre-campaign | 11 (2.9%) | 12 (3.2%) | 0.3% | |
| Campaign | 4 (1.0%) | 14 (3.4%) | 2.4% | 0.02 |
| Post-campaign | 13 (3.4%) | 10 (2.8%) | −0.6% | |
| Not recorded | ||||
| Pre-campaign | 0 (0%) | 0 (0%) | 0% | |
| Campaign | 0 (0%) | 1 (0.2%) | 0.2% | |
| Post-campaign | 0 (0%) | 0 (0%) | 0% | |
aSmall-cell and non-small cell lung cancer cases combined; %’s presented as proportions of the total known cases
bStatistical testing not conducted due to very small numbers